221 related articles for article (PubMed ID: 24558627)
1. Tolvaptan in the treatment of acute hyponatremia associated with acute kidney injury.
Gopinath S; Janga KC; Greenberg S; Sharma SK
Case Rep Nephrol; 2013; 2013():801575. PubMed ID: 24558627
[TBL] [Abstract][Full Text] [Related]
2. Vaptans for the treatment of hyponatremia.
Robertson GL
Nat Rev Endocrinol; 2011 Mar; 7(3):151-61. PubMed ID: 21283124
[TBL] [Abstract][Full Text] [Related]
3. Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
Vaghasiya RP; DeVita MV; Michelis MF
Int Urol Nephrol; 2012 Jun; 44(3):865-71. PubMed ID: 21607553
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
Nemerovski C; Hutchinson DJ
Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
[TBL] [Abstract][Full Text] [Related]
5. [Current options of treatment of hyponatremia].
Tesař V
Vnitr Lek; 2016; 62 Suppl 6():97-101. PubMed ID: 28124939
[TBL] [Abstract][Full Text] [Related]
6. Clinical review: the use of vaptans in clinical endocrinology.
Peri A
J Clin Endocrinol Metab; 2013 Apr; 98(4):1321-32. PubMed ID: 23401044
[TBL] [Abstract][Full Text] [Related]
7. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of hyponatremia: role of vaptans].
Hensen J
Internist (Berl); 2010 Dec; 51(12):1499-509. PubMed ID: 21104220
[TBL] [Abstract][Full Text] [Related]
9. [Differential diagnosis and treatment of hyponatremia].
Mydlík M; Derzsiová K; Frank K
Vnitr Lek; 2013 Jun; 59(6):478-81. PubMed ID: 23808743
[TBL] [Abstract][Full Text] [Related]
10. [Etiology, diagnostics and therapy of hyponatremias].
Laczi F
Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
[TBL] [Abstract][Full Text] [Related]
11. [Hyponatremia : The water-intolerant patient].
Hensen J
Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):440-7. PubMed ID: 22911166
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hyponatremia.
Gross P
Intern Med; 2008; 47(10):885-91. PubMed ID: 18480571
[TBL] [Abstract][Full Text] [Related]
13. [Vasopressin antagonists in treatment of hyponatremia].
Olszewski W; Głuszek J
Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients.
Nodari S; Jao GT; Chiong JR
Int J Nephrol Renovasc Dis; 2010; 3():51-60. PubMed ID: 21694929
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of hyponatremia in cancer patients.
Castillo JJ; Vincent M; Justice E
Oncologist; 2012; 17(6):756-65. PubMed ID: 22618570
[TBL] [Abstract][Full Text] [Related]
16. V2 receptor antagonist; tolvaptan.
Yi JH; Shin HJ; Kim HJ
Electrolyte Blood Press; 2011 Dec; 9(2):50-4. PubMed ID: 22438856
[TBL] [Abstract][Full Text] [Related]
17. Cerebral correlates of hyponatremia.
Nathan BR
Neurocrit Care; 2007; 6(1):72-8. PubMed ID: 17356196
[TBL] [Abstract][Full Text] [Related]
18. Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.
Gaglio P; Marfo K; Chiodo J
Dig Dis Sci; 2012 Nov; 57(11):2774-85. PubMed ID: 22732834
[TBL] [Abstract][Full Text] [Related]
19. [Hyponatremia].
Heinrich S; Wagner A; Gross P
Med Klin Intensivmed Notfmed; 2013 Feb; 108(1):53-8. PubMed ID: 22948253
[TBL] [Abstract][Full Text] [Related]
20. Hypervolemic Hyponatremia (Liver).
Solà E; Ginès P
Front Horm Res; 2019; 52():104-112. PubMed ID: 32097916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]